[Clinical evaluation of antiarrhythmic effect of thyrocalcitonin].
D001145:Arrhythmias, Cardiac / Q000097:blood / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002116:Calcitonin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002713:Chlorine / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010756:Phosphoric Acids / Q000097:blood; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013610:Tachycardia / Q000188:drug therapy
D010756:Phosphoric Acids; D002713:Chlorine; D002116:Calcitonin; D012964:Sodium; D011188:Potassium; D002118:Calcium
Klinichaskia otsenka antiartimicheskogo effekta tirokal'tsitonina